since the fda standard preparation is considered to be substantially pure dihydrostreptomycin sulfate , the content of dihydrostreptomycin base ( after allowing for known moisture content ) is assumed to be 79.2 % .
C0012317
dihydrostreptomycin sulfate
C0262967
dihydrostreptomycin